Merck’s venture arm sees $6.2bn of exits in 18 months

The exits for Merck Global Health Innovation Fund come as the general healthcare sector heats up amid the pandemic, according to William Taranto.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this